évènements à venir
Veuillez vérifier fréquemment car nous ajouterons régulièrement de nouveaux événements NTG. Nous ajouterons également des liens vers des événements de partenaires qui intéressent la communauté des familles et des professionnels de la DI et de la démence.
Note - The Toronto 2nd International Summit matter has been moved to the Past Events page. To be taken to its new setting click here.
NTG Board Members Presented at 36th Global Conference of Alzheimer’s Disease International in Krakow, Poland (April 2024)
NTG Board member Kathryn Service presented on topics related to intellectual disability and dementia at the April 2024 ADI Conference in Krakow, Poland. Ms. Service's presentation, 'A Support Group for Families with a Member with an Intellectual Disability Who is Living with Dementia: A Case Study and a Story' covered her experience with the NTG's family support group program. [click on image]
Dr. Matthew Janicki's presentation, 'Adapting Alzheimer's Disease Modifying Treatment Criteria to Accommodate Adults with Down Syndrome,' delivered by Ms. Service, addressed the work that the NTG and the Lumind IDSC Foundation have been doing with advocating for equity in access to the newly approved anti-amyloid medications for treating Alzheimer's disease. Dr. Janicki's co-authors were Hampus Hillerstrom and Dr. Richard Fisher of Lumind IDSC. [click on image]
June 6-9, 2024, Chicago, Illinois
2024 NTG Annual Conference
The NTG is contributing a partial day program to the annual AADMD conference to be held in Chicago, Illinois on June 6-9, 2024. The 'NTG Day' will be Friday, June 7th, and the NTG's contribution is an exciting and highly informative program for the morning.
Speakers will include Dr. Beth Marks of the University of Illinois Chicago, who will give a keynote address on brain health and developmental disabilities. A special plenary panel on 'Emerging Older-Age Clinical Issues in Down Syndrome and Intellectual Disabilities' will follow and include presentations by Dr. Richard Fisher, Lumind IDSC Foundation ('What we need to know about the emergence of Alzheimer’s disease modifying treatments'), Dr. Brian Chicoine, Advocate Medical Group Adult Down Syndrome Center ('What is new on diagnosis and care in primary practice for adults with Down syndrome'), and Ms. Anna Fedewa, NDSS ('What is the perspective on what matters for families and people with Down syndrome'). The Moderator will be Dr. Seth M. Keller, co-President, NTG.
NTG principals will also be involved in the afternoon breakout sessions. Dr. Seth Keller will offer a session on neurological aspects of adults with neuroatypical conditions, and Drs. Keller and Matthew Janicki will offer a Q&A Session on Alzheimer's disease modifying treatments and the new CMS GUIDE model. Dr. Teresa Moro will be the discussant.
Specifics will be announced as more information is available.
FMI: Kathryn Pears, NTG's Chief Operations Officer
Click on flyer